Crossmark

First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center

Crossref DOI link: https://doi.org/10.1007/s10072-022-06431-y

Published Online: 2022-10-05

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Skarlis, Charalampos

Markoglou, Nikolaos

Gontika, Maria

Bougea, Anastasia

Katsavos, Serafeim

Artemiadis, Artemios

Chrousos, George

Dalakas, Marinos

Stefanis, Leonidas

Anagnostouli, Maria https://orcid.org/0000-0001-8934-670X
Funding

Funding for this research was provided by:

University of Athens
License Information

Text and Data Mining valid from 2022-10-05

Version of Record valid from 2022-10-05
More Information

Article History

Received: 29 July 2022

Accepted: 26 September 2022

First Online: 5 October 2022

Declarations

:

: None.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below